124 related articles for article (PubMed ID: 19072442)
1. New drugs for hepatitis C virus.
Pockros PJ
Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):145-54. PubMed ID: 19072442
[TBL] [Abstract][Full Text] [Related]
2. Serine protease inhibitors as anti-hepatitis C virus agents.
Reiser M; Timm J
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
[TBL] [Abstract][Full Text] [Related]
3. [Antiviral treatment of chronic hepatitis C].
Berger A
Med Monatsschr Pharm; 2012 Feb; 35(2):55-60. PubMed ID: 22400430
[TBL] [Abstract][Full Text] [Related]
4. Future treatment of chronic hepatitis C.
Keeffe EB
Antivir Ther; 2007; 12(7):1015-25. PubMed ID: 18018759
[TBL] [Abstract][Full Text] [Related]
5. Future directions in therapy for chronic hepatitis C.
Jensen DM; Ascione A
Antivir Ther; 2008; 13 Suppl 1():31-6. PubMed ID: 18432161
[TBL] [Abstract][Full Text] [Related]
6. Present and future therapy for hepatitis C virus.
Cornberg M; Deterding K; Manns MP
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):781-93. PubMed ID: 17140355
[TBL] [Abstract][Full Text] [Related]
7. Directly acting antivirals against hepatitis C virus.
Soriano V; Vispo E; Poveda E; Labarga P; Martin-Carbonero L; Fernandez-Montero JV; Barreiro P
J Antimicrob Chemother; 2011 Aug; 66(8):1673-86. PubMed ID: 21652618
[TBL] [Abstract][Full Text] [Related]
8. Current and future concepts in hepatitis C therapy.
Pawlotsky JM
Semin Liver Dis; 2005 Feb; 25(1):72-83. PubMed ID: 15731999
[TBL] [Abstract][Full Text] [Related]
9. The era of direct-acting antivirals has begun: the beginning of the end for HCV?
Vachon ML; Dieterich DT
Semin Liver Dis; 2011 Nov; 31(4):399-409. PubMed ID: 22189979
[TBL] [Abstract][Full Text] [Related]
10. The race for interferon-free HCV therapies: a snapshot by the spring of 2012.
De Clercq E
Rev Med Virol; 2012 Nov; 22(6):392-411. PubMed ID: 22936636
[TBL] [Abstract][Full Text] [Related]
11. [Update on hepatitis C therapy. New drugs, treatment response monitoring and emergence of resistance].
Chueca Porcuna N; Alvarez Estévez M; Parra Ruiz J; Hernández Quero J; García García F
Enferm Infecc Microbiol Clin; 2013 Feb; 31 Suppl 1():40-7. PubMed ID: 23453230
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus virology and new treatment targets.
Meier V; Ramadori G
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
[TBL] [Abstract][Full Text] [Related]
13. Novel interferons for treatment of hepatitis C virus.
Clark V; Nelson DR
Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
[TBL] [Abstract][Full Text] [Related]
14. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
Hofmann WP; Soriano V; Zeuzem S
Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
[TBL] [Abstract][Full Text] [Related]
15. New therapies for hepatitis C virus infection.
Soriano V; Peters MG; Zeuzem S
Clin Infect Dis; 2009 Feb; 48(3):313-20. PubMed ID: 19123867
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for ribavirin in the era of hepatitis C virus direct-acting antivirals?
Feld JJ
Gastroenterology; 2012 May; 142(6):1356-9. PubMed ID: 22537443
[No Abstract] [Full Text] [Related]
17. [HCV non-responder patients: definition of non-response and treatment strategy].
Marcellin P; Bourlière M; Pawlotsky JM; Ouzan D
Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S13-9. PubMed ID: 17965630
[TBL] [Abstract][Full Text] [Related]
18. Future therapies for hepatitis C.
Pawlotsky JM; Gish RG
Antivir Ther; 2006; 11(4):397-408. PubMed ID: 16856613
[TBL] [Abstract][Full Text] [Related]
19. Another ten stories in antiviral drug discovery (part C): "Old" and "new" antivirals, strategies, and perspectives.
De Clercq E
Med Res Rev; 2009 Jul; 29(4):611-45. PubMed ID: 19260077
[TBL] [Abstract][Full Text] [Related]
20. Ribavirin in chronic hepatitis C: past and future.
Loustaud-Ratti V; Rousseau A; Marquet P; Denis F; Alain S
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):249-53. PubMed ID: 19344238
[No Abstract] [Full Text] [Related]
[Next] [New Search]